LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Co-Diagnostics Inc

Затворен

СекторЗдравеопазване

0.27 -15.62

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.27

Максимум

0.32

Ключови измерители

By Trading Economics

Приходи

-197K

-7.7M

Продажби

113K

163K

Марж на печалбата

-4,745.023

Служители

132

EBITDA

-526K

-7.8M

Дивиденти

By Dow Jones

Следващи печалби

6.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

4.2M

13M

Предишно отваряне

15.89

Предишно затваряне

0.27

Настроения в новините

By Acuity

39%

61%

130 / 371 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Co-Diagnostics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

2.09.2025 г., 23:07 ч. UTC

Придобивния, сливания и поглъщания

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2.09.2025 г., 22:10 ч. UTC

Значими двигатели на пазара

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2.09.2025 г., 21:47 ч. UTC

Печалби

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2.09.2025 г., 16:52 ч. UTC

Значими двигатели на пазара

CleanCore Solutions Shares Drop After $175 Million Private Investment

2.09.2025 г., 22:47 ч. UTC

Пазарно говорене

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2.09.2025 г., 21:40 ч. UTC

Придобивния, сливания и поглъщания

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2.09.2025 г., 21:07 ч. UTC

Печалби

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2.09.2025 г., 21:07 ч. UTC

Печалби

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Rev $17.35B >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Adj EPS 78c >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q EPS 82c >ATD.T

2.09.2025 г., 21:05 ч. UTC

Печалби

Couche-Tard 1Q Net $782.5M >ATD.T

2.09.2025 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

2.09.2025 г., 20:53 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2.09.2025 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

2.09.2025 г., 20:27 ч. UTC

Печалби

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2.09.2025 г., 20:24 ч. UTC

Придобивния, сливания и поглъщания

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2.09.2025 г., 20:18 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2.09.2025 г., 20:17 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2.09.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2.09.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2.09.2025 г., 20:15 ч. UTC

Придобивния, сливания и поглъщания

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2.09.2025 г., 19:55 ч. UTC

Печалби

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2.09.2025 г., 19:50 ч. UTC

Придобивния, сливания и поглъщания

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2.09.2025 г., 19:09 ч. UTC

Пазарно говорене

Oil Futures Gain on Geopolitical Premium -- Market Talk

2.09.2025 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2.09.2025 г., 18:12 ч. UTC

Пазарно говорене

Gold Pushes To New Record -- Market Talk

2.09.2025 г., 17:04 ч. UTC

Пазарно говорене

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2.09.2025 г., 16:57 ч. UTC

Придобивния, сливания и поглъщания

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Co-Diagnostics Inc Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

0

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

0.3495 / 0.3699Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

130 / 371 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.